Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

[ad_1] Pharma thinks it’s found the next frontier in preventing heart attacks.  Novartis, Amgen and Eli Lilly are among the drugmakers betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology. All three of the pharmaceutical giants are in late-stage trials to test whether drugs that cut … Read more

CNBC Cures: A father and a doctor on how raising a child with Angelman syndrome changed him

[ad_1] Dr. Joseph D’Orazio and his son, Gabe. Joseph D’Orazio A version of this story first appeared in the CNBC Cures newsletter. Click here to sign up. We often think of doctors as stoic figures that parachute into our lives whenever we have a problem.  They meet us at our lowest point, offer whatever help … Read more